University of Cambridge > > Cambridge Neuroscience Interdisciplinary Seminars > Immunosuppression for Parkinson's disease - a new therapeutic strategy?

Immunosuppression for Parkinson's disease - a new therapeutic strategy?

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Dr Dervila Glynn.

Note Change of Date – now June 6th 2023

Theme: Lifelong Brain Development and Brain Ageing Theme: Beyond the Neuron: glia, vascular and immune cells

Biography: Caroline Williams-Gray is a Principal Research Associate in the Department of Clinical Neurosciences, University of Cambridge, and an honorary consultant neurologist specializing in Parkinson’s disease and movement disorders. She leads a translational research group investigating the clinical and biological heterogeneity of PD, with the ultimate goal of developing more targeted therapies for different Parkinson’s subtypes. Her recent work has focused on the theory that the immune system plays a significant role in mediating the heterogeneity of PD and its progression. Her lab is investigating this using blood and CSF -based immune markers, PET neuroimaging and neuropathology in stratified PD cohorts; and she is leading the first randomized controlled trial repurposing a peripheral immunosuppressive drug (azathioprine) to slow the progression of PD.

Register in advance for this meeting:

After registering, you will receive a confirmation email containing information about joining the meeting.

This talk is part of the Cambridge Neuroscience Interdisciplinary Seminars series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity